"Centre hospitalier universitaire (CHU) de Besançon. Etablissement public de santé, qui assure une triple mission : soins, enseignement et recherche."

During the past decade, CHU de Besançon-Hôpital Saint-Jacques conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHU de Besançon-Hôpital Saint-Jacques" #1 collaborator was "MCM Vaccines B.V." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "CHU de Besançon-Hôpital Saint-Jacques" are "Acquired Immunodeficiency Syndrome" (2 trials), "HIV Infections" (2 trials), "Influenza" (1 trials), "Psoriasis" (1 trials) and "Respiratory Syncytial Virus Infections" (1 trials). Many other conditions were trialed in "CHU de Besançon-Hôpital Saint-Jacques" in a lesser frequency.

Most popular intervention types in "CHU de Besançon-Hôpital Saint-Jacques" are "Biological" (3 trials), "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "FTC/TDF" (2 trials), "Stribild" (2 trials), "CP 690,550 10 mg" (1 trials), "CP 690,550 5 mg" (1 trials) and "Etanercept 50 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "CHU de Besançon-Hôpital Saint-Jacques" are 4 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "CHU de Besançon-Hôpital Saint-Jacques". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in CHU de Besançon-Hôpital Saint-Jacques, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CHU de Besançon-Hôpital Saint-Jacques, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".